Overview

We Plan to Use Huato Zaizao Pills for Stroke Patients to Evaluate Their Efficacy and Safety and Divide 80 Subjects Into Two Groups at Random.

Status:
Recruiting
Trial end date:
2022-07-20
Target enrollment:
Participant gender:
Summary
This study is aiming to evaluate the efficacy and safety of Huatuo Zaizao pill in ischemic stroke patients who diagnosed as the phlegm and blood-stasis blocking collaterals syndrome in TCM. A total of 80 subjects will be randomly assigned to Huatuo Zaizao pill group or the control group.
Phase:
Phase 3
Details
Lead Sponsor:
Xiyuan Hospital of China Academy of Chinese Medical Sciences